Type 2 Diabetes
Research Study
Researchers at the University Health Texas Diabetes Institute are conducting a study to learn how pioglitazone, a medication used to treat type 2 diabetes, may affect liver health in adults with type 2 diabetes and non-alcoholic fatty liver disease. The study will evaluate changes in liver fat, liver function, and liver scarring over time.
Fast Facts
Adults who have type 2 diabetes and are not taking any GLP-1 medications
Ages 18-75
Compensation
up to $2130
Conducted in
San Antonio, TX
Additional Information
This study aims to understand how pioglitazone affects liver health in adults with type 2 diabetes and non-alcoholic fatty liver disease. Researchers will assess changes in liver fat, liver function, and liver scarring over the course of the study.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Have been diagnosed with type 2 diabetes
- No GLP-1 use in the past 6 months
- Live in Texas
- Not taking any medications for type 2 diabetes other than metformin or sulfonylureas (glipizide, glyburide, glimepiride)
- 18-75 years old
If you participate, you will complete approximately 12 study visits over about 6 months. These visits will include:
Screening: Attend the first 3 visits to determine whether you qualify for the study.
Treatment: If eligible, participate in a 4-month treatment period with follow-up visits approximately every 4 weeks.
Liver assessments: Complete evaluations to measure liver health, including liver fat, liver function, and liver scarring.
Final assessments: Complete follow-up evaluations after treatment to help researchers understand any changes in your liver health.
Review your results: Receive your results, which you can discuss with your primary care provider to help inform future treatment decisions.
You may receive up to $2,130 for participating in the study. Ask the study team for details about the payment schedule and any additional participation requirements.
There is no cost for you to participate in our research study.